Is there an alternative to systemic anticoagulation, as related to interventional biomedical devices? (Q36412659)

14 August 2017

title

Is there an alternative to systemic anticoagulation, as related to interventional biomedical devices? (English)

1 reference

14 August 2017

1 reference

Alexander M Seifalian

6

object named as

Alexander M Seifalian

1 reference

14 August 2017

Gemma Conn

1

1 reference

14 August 2017

Asmeret G Kidane

2

1 reference

14 August 2017

Geoffrey Punshon

3

1 reference

14 August 2017

Ruben Y Kannan

4

1 reference

14 August 2017

George Hamilton

5

1 reference

14 August 2017

publication date

1 March 2006

1 reference

Expert Review of Medical Devices

14 August 2017

published in

1 reference

14 August 2017

volume

3

1 reference

14 August 2017

issue

2

1 reference

14 August 2017

page(s)

245-261

1 reference

HEPARIN BONDING ON COLLOIDAL GRAPHITE SURFACES.

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

A synthetic antithrombin III binding pentasaccharide is now a drug! What comes next?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Heparin overview and issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Heparin-induced thrombocytopenia: clinical manifestations and management strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Mechanistic basis of heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Heparin-induced cardiac tamponade and life-threatening hyperkalema in a patient with chronic hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Early onset of hyperkalemia in patients treated with low molecular weight heparin: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Heparin-induced aldosterone suppression and hyperkalemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Anticoagulant and antiplatelet agents: their clinical and device application(s) together with usages to engineer surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

The role of recombinant hirudins in the management of thrombotic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Lepirudin: a bivalent direct thrombin inhibitor for anticoagulation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

21 January 2018

Bivalirudin: a review

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Bivalirudin: a new approach to anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Small-molecule direct antithrombins: argatroban

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

An overview of the direct thrombin inhibitor argatroban

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Argatroban in HIT type II and acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

A review of the oral direct thrombin inhibitor ximelagatran: not yet the end of the warfarin era...

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Aspirin and clopidogrel: a sweeping combination in cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

The thienopyridine derivatives (platelet adenosine diphosphate receptor antagonists), pharmacology and clinical developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Ticlopidine and clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

The thienopyridines in coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Ticlopidine-induced aplastic anemia: two new case reports, review, and meta-analysis of 55 additional cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Thrombotic thrombocytopenic purpura associated with ticlopidine in the setting of coronary artery stents and stroke prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Antiplatelet therapy for elective coronary stenting: a moving target

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

What is the role for improved long-term antiplatelet therapy after percutaneous coronary intervention?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Clopidogrel and coronary stenting: what is the next question?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

GPIIb/IIIa antagonists and other anti-integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Profound thrombocytopenia associated with tirofiban: case report and review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Immune thrombocytopenia caused by glycoprotein IIb/IIIa inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Thrombocytopenia resulting from sensitivity to GPIIb-IIIa inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Platelet glycoprotein IIb/IIIa inhibition and its clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Glycoprotein IIb/IIIa inhibition in early intent-to-stent treatment of acute coronary syndromes: EPISTENT, ADMIRAL, CADILLAC, and TARGET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Preparation of vinylated polysaccharides and photofabrication of tubular scaffolds as potential use in tissue engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Photocurable liquid biodegradable copolymers: in vitro hydrolytic degradation behaviors of photocured films of coumarin-endcapped poly(epsilon-caprolactone-co-trimethylene carbonate).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Synthesis and degradation characteristics of salicylic acid-derived poly(anhydride-esters)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Local delivery of basic fibroblast growth factor (bFGF) using adsorbed silyl-heparin, benzyl-bis(dimethylsilylmethyl)oxycarbamoyl-heparin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Formation of polymerized mixed heparin/albumin surface layer and cellular adhesional responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Sustained release of basic fibroblast growth factor and angiogenesis in a novel covalently crosslinked gel of heparin and alginate

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Liquid acrylate-endcapped biodegradable poly(epsilon-caprolactone-co-trimethylene carbonate). II. Computer-aided stereolithographic microarchitectural surface photoconstructs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Covalent immobilization of hirudin improves the haemocompatibility of polylactide-polyglycolide in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Subacute stent thrombosis and the anticoagulation controversy: changes in drug therapy, operator technique, and the impact of intravascular ultrasound.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Drug-eluting stents: costs versus clinical benefit

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Heparin-coated Wiktor stents in human coronary arteries (MENTOR trial). MENTOR Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Efficacy of heparin-coated stent in early setting of acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Improved blood compatibility of a stent graft by combining heparin coating and abciximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

A randomized trial comparing phosphorylcholine-coated stenting with balloon angioplasty as well as abciximab with placebo for restenosis reduction in small coronary arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Randomized comparison of balloon angioplasty versus silicon carbon-coated stent implantation for de novo lesions in small coronary arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Comparison of a silicon carbide coated stent versus a noncoated stent in humans: the Tenax- versus Nir-Stent Study (TENISS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Comparison of diamond-like carbon-coated stents versus uncoated stainless steel stents in coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Acute and mid-term results of phosphorylcholine-coated stents in primary coronary stenting for acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Survival of endothelial cells in vitro on Paclitaxel-loaded coronary stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Treatment of in-stent restenosis using a paclitaxel-eluting stent: acute results and long-term follow-up of a matched-pair comparison with intracoronary beta-radiation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Drug eluting stents in the infrainguinal circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

The degradative resistance of polyhedral oligomeric silsesquioxane nanocore integrated polyurethanes: an in vitro study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Polyhedral oligomeric silsesquioxane nanocomposites: the next generation material for biomedical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Interactions between endothelial cells and a poly(carbonate-silsesquioxane-bridge-urea)urethane

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Advancing vascular tissue engineering: the role of stem cell technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Biocompatibility of poly(epsilon-caprolactone)/poly(ethylene glycol) diblock copolymers with nanophase separation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Biocompatibility of poly(carbonate urethane)s with various degrees of nanophase separation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Conduit options in coronary artery bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Artificial blood vessel: the Holy Grail of peripheral vascular surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Heparin-bonded Dacron or polytetrafluoroethylene for femoropopliteal bypass grafting: a multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Basic fibroblast growth factor coating and endothelial cell seeding of a decellularized heparin-coated vascular graft

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Evaluation of a novel hirudin-coated polyester graft to physiologic flow conditions: hirudin bioavailability and thrombin uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Anticoagulant activity of sulfonated polyrotaxanes as blood-compatible materials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Covalent linkage of recombinant hirudin to a novel ionic poly(carbonate) urethane polymer with protein binding sites: determination of surface antithrombin activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Performance of a polyurethane vascular prosthesis carrying a dipyridamole (Persantin) coating on its lumenal surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Development of a hybrid cardiovascular graft using a tissue engineering approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Improving endothelial cell retention for single stage seeding of prosthetic grafts: use of polymer sequences of arginine-glycine-aspartate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

An assessment of covalent grafting of RGD peptides to the surface of a compliant poly(carbonate-urea)urethane vascular conduit versus conventional biological coatings: its role in enhancing cellular retention

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

In vivo biostability of a poly(carbonate-urea)urethane graft

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Regulation of blood coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Heparin-coated circuit in coronary surgery. A clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Heparin-coated extracorporeal circulation with full and low dose heparinization: comparison of thrombin related coagulatory effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Coating-techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Prevention of restenosis after coronary angioplasty: towards a molecular approach?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Do anticoagulation with heparin and protamine reversal alter thrombogenicity of coated and noncoated pulmonary artery catheters?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Safety of an aspirin-alone regimen after intracoronary stenting with a heparin-coated stent: final results of the HOPE (HEPACOAT and an Antithrombotic Regimen of Aspirin Alone) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Local delivery of nadroparin via hydrogel-coated angioplasty balloon: effect on platelet deposition and smooth muscle cell proliferation--an experimental study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Dosimetry study of Re-188 liquid balloon for intravascular brachytherapy using polymer gel dosimeters and laser-beam optical CT scanner

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

In vivo study of the effects of cryopreservation on heart valve xenotransplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Comparison of three myofibroblast cell sources for the tissue engineering of cardiac valves.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Heart valve tissue engineering

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Bone marrow cells in the repair and modulation of heart and blood vessels: emerging opportunities in native and engineered tissue and biomechanical materials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Silyl-heparin adsorption improves the in vivo thromboresistance of carbon-coated polytetrafluoroethylene vascular grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Surface modification with PEO-containing triblock copolymer for improved biocompatibility: in vitro and ex vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Biologically engineered protein-graft-poly(ethylene glycol) hydrogels: a cell adhesive and plasmin-degradable biosynthetic material for tissue repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Novel human endothelial cell-engineered polyurethane biomaterials for cardiovascular biomedical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Improved cell adhesion by plasma-induced grafting of L-lactide onto polyurethane surface.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Reduced Platelet Adhesion on the Surface of Polyurethane Bearing Structure of Sulfobetaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17434440.3.2.245

21 January 2018

Identifiers

DOI

10.1586/17434440.3.2.245

1 reference

14 August 2017

1 reference